/MRAI
MRAI Stock - Marpai, Inc.
Healthcare|Medical - Healthcare PlansOTC
$0.70+2.79%
+$0.02 (+2.79%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.8
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+757.1%upside
Target: $6.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MRAI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.69 – $0.71
TARGET (TP)$6.00
STOP LOSS$0.64
RISK/REWARD1:88.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta4.60
52W High$1.78
52W Low$0.66
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $28.17M | $37.16M | $24.34M | $14.23M | N/A |
| Gross Profit | $9.11M | $12.92M | $7.21M | $3.94M | $-152,367 |
| Gross Margin | 32.3% | 34.8% | 29.6% | 27.7% | N/A |
| Operating Income | $-22,087,000 | $-26,372,918 | $-26,684,000 | $-15,861,000 | $-3,367,731 |
| Net Income | $-22,088,000 | $-28,751,900 | $-26,469,000 | $-15,985,000 | $-4,414,970 |
| Net Margin | -78.4% | -77.4% | -108.7% | -112.4% | N/A |
| EPS | $-1.92 | $-4.14 | $-5.23 | $-3.15 | $-0.88 |
Company Overview
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MRAIBeat Rate
21%
Last 14 quarters
Avg Surprise
-152.0%
EPS vs Estimate
Beats / Misses
3/11
Last 12 quarters
Latest EPS
$-0.20
Q4 2025
EPS Surprise History
Q1 24
-103.1%
$-0.65vs$-0.32
Q2 24
-7.0%
$-0.46vs$-0.43
Q3 24
-141.2%
$-1.23vs$-0.51
Q4 24
+3.2%
$-0.30vs$-0.31
Q1 25
+39.1%
$-0.14vs$-0.23
Q2 25
-133.3%
$-0.21vs$-0.09
Q3 25
-211.1%
$-0.28vs$-0.09
Q4 25
-122.2%
$-0.20vs$-0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 24, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.09 | $-0.20 | -122.2% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.09 | $-0.28 | -211.1% | ✗ MISS |
Q2 2025 | May 14, 2025 | $-0.09 | $-0.21 | -133.3% | ✗ MISS |
Q1 2025 | Mar 26, 2025 | $-0.23 | $-0.14 | +39.1% | ✓ BEAT |
Q4 2024 | Nov 11, 2024 | $-0.31 | $-0.30 | +3.2% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $-0.51 | $-1.23 | -141.2% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-0.43 | $-0.46 | -7.0% | ✗ MISS |
Q1 2024 | Mar 26, 2024 | $-0.32 | $-0.65 | -103.1% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.79 | $-0.98 | -24.1% | ✗ MISS |
Q3 2023 | Aug 3, 2023 | $-1.28 | $-1.10 | +14.1% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | — | $-1.64 | — | — |
Q2 2023 | May 10, 2023 | $-0.37 | $-1.68 | -354.1% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $-0.26 | $-1.12 | -330.8% | ✗ MISS |
Q3 2022 | Aug 10, 2022 | $-0.27 | $-1.36 | -403.7% | ✗ MISS |
Q2 2022 | May 11, 2022 | — | $-1.12 | — | — |
Q1 2022 | Mar 30, 2022 | $-0.30 | $-1.36 | -353.3% | ✗ MISS |
Q4 2021 | Dec 9, 2021 | — | $-1.88 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.85 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.35 | — | — |
Frequently Asked Questions about MRAI
What is MRAI's current stock price?
Marpai, Inc. (MRAI) is currently trading at $0.70 per share. The stock has moved +2.79% today.
What is the analyst price target for MRAI?
The average analyst price target for MRAI is $6.00, based on 1 analyst.
What sector is Marpai, Inc. in?
Marpai, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the OTC exchange.
What is MRAI's market cap?
Marpai, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does MRAI pay dividends?
No, Marpai, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHGIF
Alternate Health Corp.
$0.00
Mkt Cap: $0.0B
BBIXF
Bonus BioGroup Ltd.
$0.08
Mkt Cap: $0.1B
BMKDF
BioMark Diagnostics Inc.
$0.34
Mkt Cap: $0.0B
CLIFF
Cordlife Group Limited
$0.10
Mkt Cap: $0.0B
CLYYF
Celyad Oncology S.A.
$0.18
Mkt Cap: $0.0B
CNTMF
Fluent Corp.
$0.06
Mkt Cap: $0.0B
DGNOF
DIAGNOS Inc.
$0.23
Mkt Cap: $0.0B
GBLP
Global Pharmatech, Inc.
$0.05
Mkt Cap: $0.0B
IPDQF
ImpediMed Limited
$0.02
Mkt Cap: $0.0B
POSC
Positron Corporation
$1.55
Mkt Cap: $0.0B
Explore stocks similar to MRAI for comparison